Solutions to problematic polypharmacy: Learning from the expertise of patients

British Journal of General Practice

Volumn 65, Issue 635, 2015, Pages 319-320

  Reeve, Joanne ^a   Dickenson, Michelle ^a   Harris, Jim ^b   Ranson, Ed ^a   Dohnhammer, Ulrica ^a   Cooper, Lucy ^a   Krska, Prof Janet ^c   Byng, Richard ^d   Britten, Nicky ^e  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Peninsula Patient Involvement Group (PenPIG)   (United Kingdom)

^c UNIVERSITY OF KENT   (United Kingdom)

^d UNIVERSITY OF PLYMOUTH   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTION RESEARCH; DISEASE CONTROL; EVIDENCE BASED PRACTICE; GENERAL PRACTITIONER; HUMAN; PHARMACIST; POLYPHARMACY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; RISK FACTOR; SHORT SURVEY; SKILL; CLINICAL PRACTICE; GENERAL PRACTICE; LEARNING; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA;

EVIDENCE-BASED PRACTICE; GENERAL PRACTICE; HUMANS; LEARNING; POLYPHARMACY; PRACTICE PATTERNS, PHYSICIANS';

EID: 84930509642     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp15X685465     Document Type: Short Survey

References (16)

1. Reeve J, Lynch T, Lloyd-Williams M, Payne S. From personal challenge to technical fix: the risks of depersonalised care. Health Soc Care Community 2012; 20 (2): 145-154.
2. Reeve J, Dowrick C, Freeman G, et al. Examining the practice of generalist expertise: a qualitative study identifying constraints and solutions. JRSM Short Rep 2013; 4 (12): 2042533313510155.
3. Royal Pharmaceutical Society. Medicines optimisiation: helping patients to make the most of their medicines. http://www.rpharms.com/promoting-pharmacy-pdfs/helpingpatients-make-the-most-of-their-medicines. pdf (accessed 30 Apr 2015)
4. Wilcock M, Hughes P. GP perceptions of medicines optimisation principles. Prescriber 2014; 25(18): 13-17.
5. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation. Making it safe and sound. www.kingsfund.org.uk/sites/files/kf/field/field-publication-file/polypharmacy-andmedicines-optimisation-kingsfund-nov13.pdf (accessed 6 May 2015).
6. Aronson JK. Rational prescribing, appropriate prescribing. Br J Clin Pharmacol 2004; 57(3): 229-230.
7. Krska J, Morecroft CW, Poole H, Rowe PH. The impact of using long-term medicines on quality of life: a qualitative study. Int J Clin Pharm 2013; 35(6): 1161-1169.
8. Britten N. Medicines and society: patients, professionals and the dominance of pharmaceuticals. Basingstoke: Palgrave Macmillan, 2008.
9. Denford S, Frost J, Dieppe P, et al Individualisation of drug treatments for patients with long-term conditions: a review of concepts. BMJ Open 2014; 4(3): e004172.
10. Haslbeck JW, Schaeffer D. Routines in medication management: the perspective of people with chronic conditions. Chronic Illn 2009; 5(3): 184-196.
11. Faircloth CA, Boylstein C, Rittman M, et al. Sudden illness and biographical flow in narratives of stroke recovery. Sociol Health Illn 2004; 26(2): 242-261.
12. Reeve J, Bancroft R. Generalist solutions to overprescribing: a joint challenge for clinical and academic primary care. Prim Health Care Res Dev 2014; 15(1): 72-79.
13. Green LW. Making research relevant: if it is an evidence-based practice, where is the practice-based evidence? Fam Pract 2008; 25(1): i20-i24.
14. Evans S, Scarborough H. Supporting knowledge translation through collaborative translational research initiatives: 'bridging' versus 'blurring' boundary-spanning approaches in the UK CLAHRC initiative. Soc Sci Med 2014; 106: 119-127.
15. Marshall M, Mountford J. Developing a science of improvement. JRSM 2013; 106(2): 45-50.
16. Reeve J, Blakeman T, Freeman GK, et al. Generalist solutions to complex problems: generating practice-based evidence - the example of managing multi-morbidity. BMC Fam Pract 2013; 14: 112.